2022
Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape
Hensley P, Lobo N, Bree K, Tan W, Gontero P, Williams S, Guo C, Giannarini G, Dyrskjøt L, Kamat A. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Société Internationale D’Urologie Journal 2022, 3: 245-257. DOI: 10.48083/rvzv1144.Peer-Reviewed Original ResearchPredictive biomarkersBladder cancerPredictive biomarkers of therapeutic responseBiomarkers of therapeutic responseManagement of bladder cancerBladder preservation strategiesSequence of therapyMuscle-invasive BCNon-muscle-invasiveEvolving therapeutic landscapeTherapeutic mechanism of actionAdvanced disease stateLikelihood of responseSerum-based biomarkersSystemic therapyTumor gradeTargeted therapyMechanism of actionTherapeutic responseHeterogeneous diseaseUrine-basedPrognostic capacityTherapeutic strategiesTherapeutic landscapeTherapy
2017
The Role of Robotics in the Invasive Management of Bladder Cancer
Khetrapal P, Tan W, Lamb B, Tan M, Baker H, Thompson J, Sridhar A, Kelly J, Briggs T. The Role of Robotics in the Invasive Management of Bladder Cancer. Current Urology Reports 2017, 18: 57. PMID: 28634646, DOI: 10.1007/s11934-017-0706-7.Peer-Reviewed Original ResearchConceptsRobot-assisted radical cystectomyRobot-assisted laparoscopic prostatectomyRadical cystectomyUrinary reconstructionIntracorporeal robot-assisted radical cystectomyManagement of bladder cancerOpen radical cystectomySurgical learning curveBladder cancer surgeryEnhanced recovery programmeComparison of outcomesLaparoscopic prostatectomyOncological outcomesIleus ratesBladder cancerCancer surgeryPerioperative measuresOpen techniqueInvasive managementShort recovery periodRobotic approachImprove outcomesPatient outcomesReduce recovery timeCystectomy